Canada has detected its first case of coronavirus infection from the highly mutated BA.2.86 variant of Omicron in a person in British Columbia who had not traveled outside the Pacific province, health officials said on Tuesday.
The biotech will supply Canada with fewer doses of its coronavirus vaccine while reaching a financial agreement for the forfeiting of certain doses previously scheduled for delivery.
Avian flu has reached new corners of the globe and become endemic for the first time in some wild birds that transmit the virus to poultry, according to veterinarians and disease experts, who warn it is now a year-round problem.
In response to the surge of COVID-19 in the People’s Republic of China and given the limited epidemiological and viral genomic sequence data available on these cases, the Government of Canada intends to put in place certain temporary health measures for air travelers entering Canada from China.
Summit Therapeutics Inc. said on Tuesday it would license China-based Akeso Inc.’s experimental cancer therapy in a deal worth up to $5 billion, sending its shares up 57% in premarket trade.
The U.S. national public health agency said on Friday that Omicron subvariants BQ.1 and BQ.1.1 were estimated to account for about 44.2% of COVID-19 cases in the country for the week ending Nov. 12, compared with 32.6% in the previous week.
Canada on Thursday authorized Moderna Inc.’s bivalent COVID-19 vaccine booster for people aged 18 and older, according to a notice posted on the government’s website.
Moderna Inc will supply 12 million doses of its COVID-19 shot adapted to target the Omicron variant of the coronavirus to Canada, the company said on Monday.